Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects: A Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Study

By Peeters Pierre A.M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 867-874

Adis International

Access to resources Recommend Favorite

Effects of Bilastine on T-wave Morphology and the QTc Interval: A Randomized, Double-Blind, Placebo-Controlled, Thorough QTc Study

By Graff Claus  

Clinical Drug Investigation, Vol. 32, Iss. 5, 2012-05 ,pp. : 339-351

Adis International

Access to resources Recommend Favorite

Absence of QTc prolongation with betrixaban: a randomized, double-blind, placebo- and positive-controlled thorough ECG study

By Morganroth Joel   Gretler Daniel D   Hollenbach Stanley J   Lambing Joseph L   Sinha Uma  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 5-13

Informa Healthcare

Access to resources Recommend Favorite

Testing for Positive Control Activity in a Thorough QTc Study

By Zhang Joanne  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 3, 2008-05 ,pp. : 517-528

Taylor & Francis Ltd

Access to resources Recommend Favorite

QTc interval prolongation for patients in methadone maintenance treatment: a five years follow-up study

By Fareed Ayman   Vayalapalli Sreedevi   Scheinberg Kelly   Gale Robin   Casarella Jennifer   Drexler Karen  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 4, 2013-07 ,pp. : 235-240

Informa Healthcare

Access to resources Recommend Favorite